TNYA

Tenaya Therapeutics, Inc.

4.54 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tenaya Therapeutics, Inc. stock is up 5.34% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 May’s closed higher than April. 100% of analysts rate it a buy.

About Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. discovers, develops, and delivers therapies for heart disease in the United States. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) and gDCM. It is also developing a small molecule inhibitor of histone deacetylase 6 for use in heart failure with preserved ejection fraction (HFpEF)

  • Canaccord Genuity
    Thu May 16, 11:58
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 15, 11:51
    buy
    confirm